Please read the full ASX announcement HERE.
Azure Healthcare Strong Second Half Drives Profitable Year
• Sales revenue up 9.5% on FY18 to $31.7 million in FY19
• Normalised 2H19 NPAT of $0.5 million double 1H19 result of $0.26 million
• Normalised 2H19 EBITDA of $0.77 million a 52% increase on normalized 1H19 result of $0.51 million
• R&D cash…
ASX Release – CEO Contract Renewal
The Board of Azure Healthcare Limited (ASX: AZV) announces that it has renewed its employment agreement with its Chief Executive Officer, Clayton Astles.
Azure Healthcare’s Chairman, Graeme Billings said, “We’re pleased Mr Astles will remain in his current role and continue to steer the company through the Board’s…